Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of GTF3C2 mRNA | CTD | PMID:24763279 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTF3C2 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | Gtf3c2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of GTF3C2 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GTF3C2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GTF3C2 mRNA | CTD | PMID:21296121 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GTF3C2 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of GTF3C2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of GTF3C2 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GTF3C2 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GTF3C2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Gtf3c2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of GTF3C2 gene | CTD | PMID:31683443 | acrolein | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF3C2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF3C2 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases methylation | ISO | GTF3C2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GTF3C2 gene | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF3C2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF3C2 mRNA | CTD | PMID:32699268 | atrazine | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of GTF3C2 mRNA | CTD | PMID:22378314 | avobenzone | increases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | avobenzone results in increased expression of GTF3C2 mRNA | CTD | PMID:31016361 | benzene | increases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Benzene results in increased expression of GTF3C2 mRNA | CTD | PMID:19162166 | benzo[a]pyrene | increases mutagenesis | ISO | GTF3C2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of GTF3C2 gene | CTD | PMID:25435355 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GTF3C2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GTF3C2 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of GTF3C2 gene | CTD | PMID:28505145 | bortezomib | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of GTF3C2 mRNA | CTD | PMID:20977926 | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of GTF3C2 protein | CTD | PMID:28903499 | cadmium dichloride | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of GTF3C2 mRNA | CTD | PMID:20883709 | caffeine | decreases phosphorylation | ISO | GTF3C2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of GTF3C2 protein | CTD | PMID:35688186 | chlorpyrifos | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GTF3C2 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Gtf3c2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTF3C2 gene | CTD | PMID:20938992 | cobalt dichloride | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of GTF3C2 mRNA | CTD | PMID:19376846 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of GTF3C2 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of GTF3C2 mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of GTF3C2 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | GTF3C2 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of GTF3C2 protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of GTF3C2 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GTF3C2 mRNA | CTD | PMID:25562108 | enzyme inhibitor | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GTF3C2 protein | CTD | PMID:23301498 | folic acid | multiple interactions | ISO | Gtf3c2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTF3C2 gene more ... | CTD | PMID:20938992 and PMID:22206623 | FR900359 | affects phosphorylation | ISO | GTF3C2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of GTF3C2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GTF3C2 mRNA | CTD | PMID:22061828 | L-methionine | multiple interactions | ISO | Gtf3c2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GTF3C2 gene | CTD | PMID:20938992 | lead(0) | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Lead results in decreased expression of GTF3C2 mRNA | CTD | PMID:19921347 | lead(0) | affects expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Lead affects the expression of GTF3C2 mRNA | CTD | PMID:28903495 | menadione | affects expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of GTF3C2 mRNA | CTD | PMID:20044591 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of GTF3C2 mRNA | CTD | PMID:30467583 | methyl methanesulfonate | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of GTF3C2 mRNA | CTD | PMID:23649840 | motexafin gadolinium | increases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of GTF3C2 mRNA | CTD | PMID:16357179 | ozone | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF3C2 mRNA more ... | CTD | PMID:32699268 | paracetamol | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GTF3C2 mRNA | CTD | PMID:21420995 and PMID:25704631 | parathion | increases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Parathion results in increased expression of GTF3C2 mRNA | CTD | PMID:34813904 | phenobarbital | affects expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of GTF3C2 mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GTF3C2 mRNA | CTD | PMID:22484513 | potassium chromate | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of GTF3C2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | GTF3C2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTF3C2 mRNA | CTD | PMID:22079256 | propiconazole | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | propiconazole results in decreased expression of GTF3C2 mRNA | CTD | PMID:21278054 | rac-lactic acid | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GTF3C2 mRNA | CTD | PMID:30851411 | sodium arsenite | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GTF3C2 mRNA | CTD | PMID:20883709 | succimer | multiple interactions | ISO | Gtf3c2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GTF3C2 mRNA | CTD | PMID:21641980 | tetraphene | increases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of GTF3C2 mRNA | CTD | PMID:26377693 | trichostatin A | affects expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | trichostatin A affects the expression of GTF3C2 mRNA | CTD | PMID:28542535 | triptonide | affects expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | triptonide affects the expression of GTF3C2 mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | Gtf3c2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of GTF3C2 mRNA | CTD | PMID:28973697 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of GTF3C2 mRNA | CTD | PMID:23034163 | vorinostat | decreases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of GTF3C2 mRNA | CTD | PMID:22083351 | zinc acetate | increases expression | ISO | GTF3C2 (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of GTF3C2 mRNA | CTD | PMID:16357179 | |